Whole cell Pertussis
-
WHO GMP for Biological Products. Proposed replacement of: TRS 822, Annex 1
pdf, 1.08Mb -
GMP Comment Form
doc, 78kb -
Recommendations to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle vaccines. Proposed replacement of: TRS 962, Annex 1
pdf, 1.31Mb -
HPV Comment Form
doc, 58kb
UPCOMING EVENTS
- WHO Informal Consultation on Regulatory considerations for evaluation of Ebola Vaccines intended for emergency use, WHO/HQ Geneva, Switzerland, 18-19 March 2015
- WHO Informal Consultation on Stability Evaluation of Vaccines for use in a Controlled Temperature Chain, WHO/HQ Geneva, Switzerland, 24–26 March 2015
- WHO Informal Consultation on Amendment for Similar Biotherapeutic products of monoclonal antibodies, WCC, Geneva, Switzerland, 27–28 April 2015
- WHO Informal Consultation on Regulatory risk assessment for biotherapeutic products, WCC, Geneva, Switzerland, 29–30 April 2015
Contacts
Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971